Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Nov 24, 2021 6:51am

627 Views

Post# 34160354

RE:RE:RE:Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

The sad reality is that there`s no opposition to its`use among consumers to start with but if you think that the EU are going to roll over and fail to protect their Company from Competition just because more lives could be saved then watch this space...

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario